Literature DB >> 10556821

Dual role of TNF-alpha in NK/LAK cell-mediated lysis of chronically HIV-infected U1 cells. Concomitant enhancement of HIV expression and sensitization of cell-mediated lysis.

C Fortis1, P Biswas, L Soldini, F Veglia, A M Careddu, F Delfanti, B Mantelli, M Murone, A Lazzarin, G Poli.   

Abstract

The U937-derived chronically HIV-infected U1 cell line and uninfected U937 cell clones were efficiently lysed by both unstimulated (NK) and IL-2-stimulated (lymphokine-activated killer; LAK) peripheral blood mononuclear cells (PBMC) of healthy HIV-seronegative donors. Pretreatment of target cells with IFN-gamma down-modulated killing of both U1 cells and two U937 cell clones, and up-regulated MHC class I expression. In contrast, TNF-alpha enhanced the sensitivity of infected U1 cells, but not of U937 cell clones to NK / LAK cell lysis. Co-cultivation of IL-2-stimulated PBMC with U1 cells triggered expression and replication of HIV by cell-cell contact, and this effect was inhibited by anti-TNF-alpha antibodies (Ab); virus production was partially inhibited by zidovudine. Of interest, anti-TNF-alpha Ab protected U1 cells from LAK cell activity. Thus, TNF-alpha can induce HIV expression from chronically infected U1 cells, but also plays an important role in sensitizing these cells to lysis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556821     DOI: 10.1002/(SICI)1521-4141(199911)29:11<3654::AID-IMMU3654>3.0.CO;2-B

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Toll-like receptor 7 and 8 polymorphisms: associations with functional effects and cellular and antibody responses to measles virus and vaccine.

Authors:  Holly D Clifford; Stephanie T Yerkovich; Siew-Kim Khoo; Guicheng Zhang; John Upham; Peter N Le Souëf; Peter Richmond; Catherine M Hayden
Journal:  Immunogenetics       Date:  2011-09-23       Impact factor: 2.846

2.  Binding of LFA-1 (CD11a) to intercellular adhesion molecule 3 (ICAM-3; CD50) and ICAM-2 (CD102) triggers transmigration of human immunodeficiency virus type 1-infected monocytes through mucosal epithelial cells.

Authors:  Marie-Paule Carreno; Nicolas Chomont; Michel D Kazatchkine; Theano Irinopoulou; Corrine Krief; Ali-Si Mohamed; Laurent Andreoletti; Mathieu Matta; Laurent Belec
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 3.  Dendritic cells and natural killer cells in the pathogenesis of HIV infection.

Authors:  Claudio Fortis; Guido Poli
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

4.  Human uterine natural killer cells but not blood natural killer cells inhibit human immunodeficiency virus type 1 infection by secretion of CXCL12.

Authors:  Teddy F Mselle; Alexandra L Howell; Mimi Ghosh; Charles R Wira; Charles L Sentman
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

5.  Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome.

Authors:  Dwight L Evans; Kevin G Lynch; Tami Benton; Benoit Dubé; David R Gettes; Nancy B Tustin; Jian Ping Lai; David Metzger; Steven D Douglas
Journal:  Biol Psychiatry       Date:  2007-10-22       Impact factor: 13.382

6.  Loss of NK stimulatory capacity by plasmacytoid and monocyte-derived DC but not myeloid DC in HIV-1 infected patients.

Authors:  Adel Benlahrech; Frances Gotch; Peter Kelleher; Steven Patterson
Journal:  PLoS One       Date:  2011-03-08       Impact factor: 3.240

Review 7.  A dendrite in every pie: myeloid dendritic cells in HIV and SIV infection.

Authors:  Elizabeth R Wonderlich; Simon M Barratt-Boyes
Journal:  Virulence       Date:  2012-11-15       Impact factor: 5.882

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.